ArticleBMC pulmonary medicine2026
Concomitant pulmonary embolism and severe thrombocytopenia associated with an APS-like autoimmune thrombophilic condition: a case report.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe thrombocytopenia accompanied by acute pulmonary embolism (PE) represents a rare and challenging clinical scenario, particularly in elderly patients, where both thrombotic and hemorrhagic risks coexist.We report the case of a 78-year-old man who presented with acute dizziness and was found to have severe thrombocytopenia (platelet count 32 × 10⁹/L) and objectively confirmed pulmonary embolism. Given the high bleeding risk, prophylactic-dose low-molecular-weight heparin was initiated. Shortly thereafter, the patient developed intracerebral hemorrhage, prompting immediate discontinuation of anticoagulation.Extensive evaluation excluded heparin-induced thrombocytopenia, thrombotic microangiopathy, malignancy, and infection. Autoimmune testing revealed persistent isolated positivity for anti–β2-glycoprotein I IgM antibodies, suggesting an APS-like autoimmune thrombophilic state, although high-specificity classification criteria for antiphospholipid syndrome were not fully met.Notably, both thrombocytopenia and pulmonary embolism gradually improved without further anticoagulation. At follow-up, no recurrent thrombosis occurred.This case highlights the diagnostic uncertainty and therapeutic complexity of managing venous thromboembolism in the setting of severe thrombocytopenia and APS-spectrum autoimmunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.